KRAS and neoplasm: VD inhibited tumor growth, upregulated CDK inhibitors p21 and p27 and induced cell cycle arrest at G1/S checkpoint proportionally. Tumor growth was also inhibited in mutant-K-Ras-transfected and endogenous K-Ras-activating mutation cell lines.